Paclitaxel plus cisplatin vs. 5-fluorouracil plus cisplatin as first-line treatment for patients with advanced squamous cell esophageal cancer.

作者：Ying Liu, Z P Ren, Long Yuan, Shuning Xu, Zhihua Yao, Lei Qiao, Ke Li · 发表于：PubMed · 年份：2016 · 被引用次数：59 · 研究领域：Esophageal Cancer Research and Treatment、Gastric Cancer Management and Outcomes、Gastrointestinal Tumor Research and Treatment

=0.204). The first-line chemotherapy of paclitaxel plus cisplatin had better median progression-free survival than 5-fluorouracil plus cisplatin in patients with advanced esophageal squamous cell carcinoma with tolerable toxicities.